Literature DB >> 31178022

Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study.

Bing-Yang Zhou1, Di Sun1, Chun Wang2, Na-Qiong Wu1, Yuan-Lin Guo1, Cheng-Gang Zhu1, Ying Gao1, Geng Liu1, Qian Dong1, Jian-Jun Li3.   

Abstract

BACKGROUND: Although lipoprotein(a) (Lp(a)) has been regarded as an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), its predictive role in outcomes in stable coronary artery disease (CAD) has been undetermined. The aim of the present study was to investigate the relations of Lp(a) to the coronary severity and events in Chinese patients with angiography-proven stable CAD.
METHODS: A total of 3,278 patients with stable CAD were consecutively enrolled and the coronary severity was evaluated by the Gensini Score (GS) system. Patients were divided into two groups according to the median of GS: high GS group (n=1,585) and low GS group (n=1,693). The associations of continuous Lp(a), Lp(a) ≥300mg/L, and tertiles of Lp(a) with GS and events were respectively evaluated.
RESULTS: Patients in the high GS group had significantly higher concentrations of Lp(a). In addition, the multivariate Cox regression analysis indicated that elevated Lp(a) (odds ratio: 1.164, 95% confidence interval: 1.005-1.349), Lp(a) ≥300mg/L (odds ratio: 1.200, 95% confidence interval: 1.028-1.401), and the highest tertile of Lp(a) (odds ratio: 1.205, 95% confidence interval: 1.010-1.438) were statistically associated with GS after adjusted for potential confounders. However, although 215 (6.56%) events were established during a median of follow-up over 10,170 patient-years, no relationship between Lp(a) and events was found.
CONCLUSIONS: In this Chinese cohort study on stable CAD with moderate sample size and follow-up duration, data showed that Lp(a) was significantly associated with the coronary severity while not with cardiovascular events, similar to several studies, suggesting that further study is needed regarding the role of Lp(a) in ASCVD.
Copyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Events; Gensini Score; Lipoprotein(a)

Mesh:

Substances:

Year:  2018        PMID: 31178022     DOI: 10.1016/j.hlc.2018.05.190

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  4 in total

1.  The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels.

Authors:  Weifeng Xu; Haiwang Guan; Da Gao; Zicheng Wang; Yanna Ba; Hao Yang; Wenjun Shen; Jiangfang Lian; Jianqing Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-12       Impact factor: 3.168

2.  Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study.

Authors:  Chunyue Guo; Han Cao; Guangliang Shan; Wei Zhao; Han Zhang; Kaijun Niu; Ze Cui; Naijun Tang; Kuo Liu; Li Pan; Xiaoyan Han; Zhengfang Wang; Ge Meng; Jixin Sun; Anqi Shan; Yuxiang Yan; Huijing He; Zhiyuan Xu; Yajing Cao; Wenjuan Peng; Yanyan Sun; Yunyi Xie; Xiaohui Liu; Bingxiao Li; Fuyuan Wen; Ling Zhang
Journal:  Ann Transl Med       Date:  2021-01

3.  Relationship Between Lipoprotein(a) and Angiographic Severity of Femoropopliteal Lesions.

Authors:  Koji Yanaka; Hirokuni Akahori; Takahiro Imanaka; Kojiro Miki; Nagataka Yoshihara; Toshio Kimura; Takamasa Tanaka; Masanori Asakura; Masaharu Ishihara
Journal:  J Atheroscler Thromb       Date:  2020-08-29       Impact factor: 4.928

4.  Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study.

Authors:  Yan Zhang; Jing-Lu Jin; Ye-Xuan Cao; Hui-Hui Liu; Hui-Wen Zhang; Yuan-Lin Guo; Na-Qiong Wu; Ying Gao; Qi Hua; Yan-Fang Li; Rui-Xia Xu; Chuan-Jue Cui; Geng Liu; Qian Dong; Jing Sun; Jian-Jun Li
Journal:  J Transl Med       Date:  2020-10-01       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.